Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics.

Tsai M, Lu Z, Wientjes MG, Au JL.

J Control Release. 2013 Dec 28;172(3):737-44. doi: 10.1016/j.jconrel.2013.09.011.

2.

In vitro and in vivo correlation of paclitaxel-loaded polymeric microparticles.

Park K.

J Control Release. 2013 Dec 28;172(3):1162. doi: 10.1016/j.jconrel.2013.11.015. No abstract available.

PMID:
24315459
3.

Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading.

Lee WL, Guo WM, Ho VH, Saha A, Chong HC, Tan NS, Tan EY, Loo SC.

Acta Biomater. 2015 Nov;27:53-65. doi: 10.1016/j.actbio.2015.08.051.

PMID:
26340886
5.

Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel.

Tsai M, Lu Z, Wang J, Yeh TK, Wientjes MG, Au JL.

Pharm Res. 2007 Sep;24(9):1691-701.

6.

Microparticles produced by the hydrogel template method for sustained drug delivery.

Lu Y, Sturek M, Park K.

Int J Pharm. 2014 Jan 30;461(1-2):258-69. doi: 10.1016/j.ijpharm.2013.11.058.

7.
8.

The anti-melanoma efficiency of the intratumoral injection of cucurbitacin-loaded sustained-release carriers: a PLGA particle system.

Jianbo G, Xue L, Hongdan Y, Zhaohui T, Xing T, Chenchen C, Jinghua X, Hui X.

J Pharm Sci. 2013 Aug;102(8):2550-63. doi: 10.1002/jps.23604.

PMID:
23729371
9.

Activity of drug-loaded tumor-penetrating microparticles in peritoneal pancreatic tumors.

Lu Z, Tsai M, Wang J, Cole DJ, Wientjes MG, Au JL.

Curr Cancer Drug Targets. 2014;14(1):70-8.

PMID:
24200079
10.

Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiation.

Wang J, Ng CW, Win KY, Shoemakers P, Lee TK, Feng SS, Wang CH.

J Microencapsul. 2003 May-Jun;20(3):317-27.

PMID:
12881113
11.

Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model.

Amoozgar Z, Wang L, Brandstoetter T, Wallis SS, Wilson EM, Goldberg MS.

Biomacromolecules. 2014 Nov 10;15(11):4187-94. doi: 10.1021/bm5011933.

PMID:
25251833
12.

In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.

Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Wan Kim S, Seo MH.

J Control Release. 2001 May 14;72(1-3):191-202.

PMID:
11389998
13.

Paclitaxel-loaded poly(D,L-lactide-co-glycolide) nanoparticles for radiotherapy in hypoxic human tumor cells in vitro.

Jin C, Bai L, Wu H, Liu J, Guo G, Chen J.

Cancer Biol Ther. 2008 Jun;7(6):911-6.

PMID:
18367873
14.

Polymeric micelles and nanoemulsions as drug carriers: Therapeutic efficacy, toxicity, and drug resistance.

Gupta R, Shea J, Scafe C, Shurlygina A, Rapoport N.

J Control Release. 2015 Aug 28;212:70-7. doi: 10.1016/j.jconrel.2015.06.019.

PMID:
26091919
15.

Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.

Ong BY, Ranganath SH, Lee LY, Lu F, Lee HS, Sahinidis NV, Wang CH.

Biomaterials. 2009 Jun;30(18):3189-96. doi: 10.1016/j.biomaterials.2009.02.030.

PMID:
19285718
16.
17.

Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.

Wang G, Yu B, Wu Y, Huang B, Yuan Y, Liu CS.

Int J Pharm. 2013 Mar 25;446(1-2):24-33. doi: 10.1016/j.ijpharm.2013.02.004.

PMID:
23402977
18.

Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer.

Lu Z, Tsai M, Lu D, Wang J, Wientjes MG, Au JL.

J Pharmacol Exp Ther. 2008 Dec;327(3):673-82. doi: 10.1124/jpet.108.140095.

19.
20.

[Surface-modified paclitaxel-loaded nanoparticles as local delivery system for the prevention of vessel restenosis].

Mei L, Song CX, Jin X, Che YZ, Jin Z, Sun HF.

Yao Xue Xue Bao. 2007 Jan;42(1):81-6. Chinese.

PMID:
17520813
Items per page

Supplemental Content

Support Center